Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 2/14 cls
Depomed Inc. (NASDAQ:DEPO) Roth Capital Partners Scott Henry Downgrade Neutral (from buy) 1% $12.30
Henry downgraded on the belief that the share price has caught up to fundamentals after doubling in the past 12 months. He raised his target to $12.50 from $12 after increasing his sales forecasts for migraine

Read the full 776 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE